← Eichor
Condition: Mash With Fibrosis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Mash With Fibrosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
NA · 2 location(s) · Pichamol Jirapinyo, MD, MPH · NCT06138821Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH
Phase 2 · 17 location(s) · Madrigal Pharmaceuticals, Inc. · NCT07335601A Study to Test How Well Different Doses of BI 3804379 Are Tolerated by Healthy People and Patients With Metabolic Dysfu
Phase 1 · 1 location(s) · Boehringer Ingelheim · NCT06575400A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction
Phase 3 · 356 location(s) · Akero Therapeutics, Inc · NCT06215716Global Research Initiative for Patients Screening on MASH
Phase N/A · 13 location(s) · Julius Clinical · NCT05651724A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Phase 3 · 361 location(s) · 89bio, Inc. · NCT06318169Digoxin In NASH (CODIN)
Phase 2 · 2 location(s) · Yale University · NCT06588699A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction-
Phase 2 · 27 location(s) · Boehringer Ingelheim · NCT07325526A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Phase 2 · 30 location(s) · GlaxoSmithKline · NCT06920043Endoscopic Ultrasound Shear Wave Elastography Study
Phase N/A · 2 location(s) · Olympus Corporation of the Americas · NCT06592820A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 317 location(s) · 89bio, Inc. · NCT06419374LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or A
Phase 3 · 525 location(s) · Boehringer Ingelheim · NCT06632444Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH)
NA · 2 location(s) · Queen Mary University of London · NCT07013916A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfuncti
Phase 1/Phase 2 · 6 location(s) · Regeneron Pharmaceuticals · NCT05648214
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.